GATA1 Mutation In Transient Leukemia (TL) and Myeloid Leukemia of Down Syndrome

GATA1 Mutation In Transient Leukemia (TL) and Myeloid Leukemia of Down Syndrome

Show other versions (1)

Bibliographic Details
Main Authors:	Reinhardt, K, Kate, A, Bohmer, K, Vyas, P, Dirk, R
Format:	Conference item
Published:	2010

Similar Items

GATA1 Mutation In Transient Leukemia (TL) and Myeloid Leukemia of Down Syndrome
by: Reinhardt, K, et al.
Published: (2010)

Analysis of GATA1 mutations in Down syndrome transient myeloproliferative disorder and myeloid leukemia.
by: Alford, K, et al.
Published: (2011)

GATA1s induces hyperproliferation of eosinophil precursors in Down syndrome transient leukemia
by: Maroz, A, et al.
Published: (2014)

GATA1s induces hyperproliferation of eosinophil precursors in Down syndrome transient leukemia.
by: Maroz, A, et al.
Published: (2014)

Myeloid pre-leukemia and leukemia of Down syndrome
by: Cruz Hernandez, D, et al.
Published: (2020)

GATA1 and cooperating mutations in myeloid leukaemia of Down syndrome
by: Garnett, C, et al.
Published: (2019)

Myeloid leukemia in children 4 years or older with Down syndrome often lacks GATA1 mutation and cytogenetics and risk of relapse are more akin to sporadic AML.
by: Hasle, H, et al.
Published: (2008)

Acute leukemias in children with Down syndrome.
by: Zwaan, C, et al.
Published: (2010)

Acute leukemias in children with Down syndrome.
by: Zwaan, M, et al.
Published: (2008)

Sensitive, rapid diagnostic test for transient abnormal myelopoiesis and myeloid leukemia of Down syndrome
by: Cruz Hernandez, D, et al.
Published: (2020)

Mechanisms of progression of myeloid preleukemia to transformed myeloid leukemia in children with Down syndrome
by: Labuhn, M, et al.
Published: (2019)

JAK mutations in Down syndrome - associated transient myeloproliferative disorder and acute megakaryocytic leukemia
by: Vyas, P, et al.
Published: (2008)

GATA1 mutation analysis demonstrates two distinct primary leukemias in a child with down syndrome; implications for leukemogenesis.
by: Hellebostad, M, et al.
Published: (2005)

Down syndrome preleukemia and leukemia.
by: Maloney, K, et al.
Published: (2014)

Analysis of JAK3, JAK2, and C-MPL mutations in transient myeloproliferative disorder and myeloid leukemia of Down syndrome blasts in children with Down syndrome.
by: Norton, A, et al.
Published: (2007)

Molecular insights into Down syndrome-associated leukemia.
by: Vyas, P, et al.
Published: (2007)

Natural history of GATA-1 mutations in Down syndrome.
by: Ahmed, M, et al.
Published: (2003)

Abnormalities in the myeloid progenitor compartment in Down syndrome fetal liver precede acquisition of GATA1 mutations.
by: Tunstall-Pedoe, O, et al.
Published: (2008)

Natural history of GATA1 mutations in Down syndrome.
by: Ahmed, M, et al.
Published: (2004)

GATA1-mutant clones are frequent and often unsuspected in babies with Down syndrome: identification of a population at risk of leukemia.
by: Roberts, I, et al.
Published: (2013)

Heterogeneous leukemia stem cells in myeloid blast phase chronic myeloid leukemia
by: Kinstrie, R, et al.
Published: (2016)

Frequent Mutation of the Polycomb-Associated Gene ASXL1 In Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
by: Fernandez-Mercado, M, et al.
Published: (2010)

Analysis of GATA-1 mutations in chronic myeloid leukaemia.
by: Halsey, C, et al.
Published: (2006)

Recurrent ETNK1 mutations in atypical chronic myeloid leukemia.
by: Gambacorti-Passerini, C, et al.
Published: (2015)

GATA1 mutational analysis in chronic myeloid leukaemia.
by: Halsey, C, et al.
Published: (2007)

Severe TMD/AMKL with GATA1 mutation in a stillborn fetus with Down syndrome.
by: Heald, B, et al.
Published: (2007)

Mutations in PTPN11 are rare in adult myelodysplastic syndromes and acute myeloid leukemia.
by: Watkins, F, et al.
Published: (2004)

Recurrent SETBP1 mutations in atypical chronic myeloid leukemia
by: Piazza, R, et al.
Published: (2013)

Recurrent SETBP1 mutations in atypical chronic myeloid leukemia.
by: Piazza, R, et al.
Published: (2013)

Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia.
by: Boultwood, J, et al.
Published: (2010)

An overview of targeted therapies in acute myeloid leukemia
by: Turkalj, S, et al.
Published: (2023)

TP53-mutated myelodysplastic syndrome and acute myeloid leukemia: biology, current therapy, and future directions
by: Daver, NG, et al.
Published: (2022)

Mutational analysis of disease relapse in patients allografted for acute myeloid leukemia
by: Quek, L, et al.
Published: (2016)

Autophagy in the pathogenesis of myelodysplastic syndrome and acute myeloid leukemia.
by: Watson, A, et al.
Published: (2011)

Modelling the progression of a preleukemic stage to overt leukemia in children with down syndrome
by: Labuhn, M, et al.
Published: (2018)

Assessment of minimal residual disease in acute myeloid leukemia.
by: Grimwade, D, et al.
Published: (2010)

Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia.
by: Vyas, P, et al.
Published: (2015)

Myelodysplastic syndrome due to somatic GATA1 mutation.
by: Freson, K, et al.
Published: (2004)

Autophagy in hematopoiesis and acute myeloid leukemia
by: Watson, A
Published: (2014)

Coexistence of LMPP-like and GMP-like leukemia stem cells in acute myeloid leukemia.
by: Goardon, N, et al.
Published: (2011)